Week41, 2023
1. Influenza activity remains low nationally, with 1.3% of clinical lab specimens testing positive for influenza this week.
2. Of the positive specimens in clinical labs, 69.1% were Influenza A and 30.9% were Influenza B.
3. Public health labs reported that 78.0% of positive specimens were Influenza A (93.9% were A(H1N1) and 6.1% A(H3N2)) and 22.0% were Influenza B, all of which belonged to the Victoria lineage.
4. Outpatient visits for influenza-like illness (ILI) accounted for 2.3% of patient visits, a stable level that remains below the national baseline of 2.9%.
5. Hospitalization rates remain low with a cumulative rate of 0.3 per 100,000 population and an increase of 1,228 hospital admissions this week, mostly in regions 5, 6, 8, and 9.
6. Influenza-related deaths constituted 0.05% of total deaths this week, with no change from the previous week.
7. One pediatric influenza-associated death from the 2022â€“2023 season was reported, involving Influenza A(H1N1).
8. Vaccination is emphasized, with the CDC recommending annual vaccination for individuals aged six months and older by the end of October.
9. SARS-CoV-2, RSV, and other respiratory viruses are co-circulating, contributing to the respiratory disease burden.
10. Slight increases in respiratory illness and influenza positivity were reported in specific regions, potentially signaling areas of rising flu activity.